Cargando…
Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis
INTRODUCTION: The first-line combination therapy for HIV-associated cryptococcal meningitis (CM), a condition of high mortality particularly in the first two weeks of treatment, consists of amphotericin B plus flucytosine (5-FC). Given that 5-FC remains unavailable in many countries, the knowledge o...
Autores principales: | Concha-Velasco, Fátima, González-Lagos, Elsa, Seas, Carlos, Bustamante, Beatriz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371305/ https://www.ncbi.nlm.nih.gov/pubmed/28355252 http://dx.doi.org/10.1371/journal.pone.0174459 |
Ejemplares similares
-
Failure of Early Mycological Clearance in HIV-Negative Cryptococcal Meningitis
por: Su, Zhihui, et al.
Publicado: (2023) -
Clinical and mycological implications of cryptococcal meningitis in Iran
por: Bashardoust, Bahareh, et al.
Publicado: (2023) -
Treatment for HIV‐associated cryptococcal meningitis
por: Tenforde, Mark W, et al.
Publicado: (2018) -
Immune correlates of HIV-associated cryptococcal meningitis
por: Tenforde, Mark W., et al.
Publicado: (2017) -
1593 Predictors of Mortality for HIV-associated Cryptococcal Meningitis
por: Nimitvilai, Sireethorn, et al.
Publicado: (2014)